MWE China Law Offices and its strategic alliance partner McDermott Will & Emery are proud to co-host our annual Shanghai Life Sciences Forum in partnership with the Redefining Early Stage Investments (RESI) conference.
This...more
10/30/2019
/ Acquisitions ,
Corporate Governance ,
Cross-Border Transactions ,
Events ,
Foreign Investment ,
Health Care Providers ,
Investment Funds ,
Investment Opportunities ,
Investors ,
Life Sciences ,
Medical Devices ,
Mergers ,
Outbound Transactions ,
Pharmaceutical Industry ,
Popular ,
Private Equity ,
Regulatory Requirements ,
Venture Capital
Data Inspections in China: Increased Supervision and Compliance -
Data protection inspections have become more frequent for companies with operations in China. Many companies are struggling for guidance on how to...more
The Chinese Government’s wide-ranging bribery and corruption investigation into the pharmaceutical industry takes a new turn every week. Media reports contain numerous incidents of purported whistleblowers making allegations...more